Skip to content
Search

Latest Stories

Sajid Javid replaces Matt Hancock as health secretary

Britain's new health secretary Sajid Javid said on Sunday (Jun 27) his priority was to oversee a return to normal from the Covid-19 pandemic, and praised his predecessor Matt Hancock who was forced to resign after breaking social-distancing rules.

Javid, a former finance minister, starts his new role with a pressing to-do list - coronavirus cases are rising, hospitals are warning of a growing backlog of people needing care and staff are battling burn-out in their fight against the disease.


"We are still in a pandemic, and I want to see that come to an end as soon as possible, and that will be my most immediate priority to see that we can return to normal as soon and as quickly as possible," he told BBC News.

Javid said later: "Thanks to the fantastic efforts of our NHS and social care staff who work tirelessly every day, and our phenomenal vaccination programme, we have made enormous progress in the battle against this dreadful disease."

Hancock resigned after he admitted breaking Covid-19 guidance by kissing and embracing an aide in his office, angering colleagues and the public during lockdown.

Downing Street on Saturday (June 26) published Hancock's resignation letter to Boris Johnson and the prime minister's response, in which he said he was sorry to receive it.

Around the same time of Saturday evening, Hancock tweeted:

"We have worked so hard as a country to fight the pandemic," Hancock said in the letter. "The last thing I would want is for my private life to distract attention from the single-minded focus that is leading us out of this crisis."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less